{
  "id": "cluster_47_doc4",
  "content": "Quality assurance report for Alderwood Neurosciences highlights complications in 3% of neuromodulation cases. Case review notes excellent recovery for patient residing at 1842 Crestview Lane, correlating with specialized post-op protocol development. Device rep training scheduled April 15, 2024.",
  "metadata": {
    "format": "provider_report"
  }
}